Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

A case of idiopathic hypertrophic pachymeningitis presented with seizures

  • Kim, Minju (Department of Neurology, Jeju National University College of Medicine) ;
  • Kim, Joong-Goo (Department of Neurology, Jeju National University College of Medicine) ;
  • Kang, Chul-Hoo (Department of Neurology, Jeju National University College of Medicine) ;
  • Kim, Hong Jun (Department of Neurology, Jeju National University College of Medicine) ;
  • Kang, Sa-Yoon (Department of Neurology, Jeju National University College of Medicine) ;
  • Oh, Jung-Hwan (Department of Neurology, Jeju National University College of Medicine)
  • Received : 2022.07.20
  • Accepted : 2022.08.25
  • Published : 2022.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Idiopathic hypertrophic pachymeningitis (IHP) is a rare disease involving localized inflammatory thickening of the intracranial or spinal dura mater without an identified cause. Seizure is a very unusual presentation of IHP. We present a 58-year-old-female patient with seizures caused by IHP. This case indicates that although IHP is rare, it has the potential to cause seizures.

Keywords

References

  1. Xiao X, Fu D, Feng L. Hypertrophic pachymeningitis in a southern Chinese population: a retrospective study. Front Neurol 2020;11:565088. https://doi.org/10.3389/fneur.2020.565088
  2. Margoni M, Barbareschi M, Rozzanigo U, Sarubbo S, Chioffi F, Tanel R. Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus. Neurol Sci 2019;40:2193-2195. https://doi.org/10.1007/s10072-019-03954-9
  3. Huang Y, Chen J, Gui L. A case of idiopathic hypertrophic pachymeningitis presenting with chronic headache and multiple cranial nerve palsies: a case report. Medicine (Baltimore) 2017;96:e7549. https://doi.org/10.1097/MD.0000000000007549
  4. Choi YJ, Kim SH, Kim JY, Cho YJ, Lee SN, Koo H, et al. A case of idiopathic localized hypertrophic pachymeningitis presented with partial seizures. J Korean Epilepsy Soc 2004;8:163-166.
  5. Jang Y, Lee ST, Jung KH, Chu K, Lee SK. Rituximab treatment for idiopathic hypertrophic pachymeningitis. J Clin Neurol 2017;13:155-161. https://doi.org/10.3988/jcn.2017.13.2.155
  6. Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ. Idiopathic hypertrophic pachymeningitis. Neurology 2004;62:686-694. https://doi.org/10.1212/01.WNL.0000113748.53023.B7
  7. Scramstad C, Jackson AC. Cerebrospinal fluid pleocytosis in critical care patients with seizures. Can J Neurol Sci 2017;44:343-349. https://doi.org/10.1017/cjn.2016.442
  8. Jia H, Xie X, Qi F, Wang L, Wang L, Che F. Anti-NMDAR encephalitis with simultaneous hypertrophic pachymeningitis in a 68-year-old male: a rare case report. BMC Neurol 2019;19:215. https://doi.org/10.1186/s12883-019-1444-x
  9. Navalpotro-Gomez I, Vivanco-Hidalgo RM, Cuadrado-Godia E, Medrano-Martorell S, Alameda-Quitllet F, Villalba-Martinez G, et al. Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis. J Neurol Sci 2016;367:232-236. https://doi.org/10.1016/j.jns.2016.06.025